Ledger.Open graph →
SEC Form D · filed August 22, 2025

Incyclix Bio, LLC

Offering
$20.0M
Sold
$11.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Durham, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Norman N. Sharpless · Durham, NCDirectorFredric N. Eshelman · Houston, TXExec · DirectorPatrick Roberts · SPENCERPORT, NYExec · DirectorNorman N. Sharpless · Durham, NCDirectorFredric N. Eshelman · Houston, TXExec · DirectorPatrick Roberts · SPENCERPORT, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗